Free Trial
→ Nvidia’s Next Big Move Comes on Feb. 26 (From Weiss Ratings) (Ad)

Sernova Q4 2023 Earnings Report

Sernova logo
C$0.20 0.00 (0.00%)
As of 02/21/2025 03:59 PM Eastern
Earnings HistoryForecast

Sernova EPS Results

Actual EPS
-C$0.04
Consensus EPS
-C$0.03
Beat/Miss
Missed by -C$0.01
One Year Ago EPS
N/A

Sernova Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sernova Announcement Details

Quarter
Q4 2023
Date
1/29/2024
Time
N/A

Conference Call Resources

Sernova Earnings Headlines

Sernova Corp.: Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
February 11, 2025 | finanznachrichten.de
Jobs Reports Due for Next Week
January 31, 2025 | theglobeandmail.com
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of companies partnering with Nvidia on its latest AI Superproject … Companies we refer to as Nvidia's "Silent Partners" … And they could benefit greatly as well on Feb. 26.
February 22, 2025 | Weiss Ratings (Ad)
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
January 30, 2025 | markets.businessinsider.com
School of Visual Arts
November 1, 2024 | usnews.com
Sernova Announces Key New Executive Appointments
October 11, 2024 | finance.yahoo.com
See More Sernova Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sernova? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sernova and other key companies, straight to your email.

About Sernova

Sernova (TSE:SVA) operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

View Sernova Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles